|
Acetogenins
|
D054378 |
[Polyketides of up to a few dozen carbons in length, formed by chain extension of multiple PROPIONATES and oxygenated to form tetrahydrofuran and lactone rings along the length of the chain. They are found in ANNONACEAE and other PLANTS. Related compounds cyclize to MACROLIDES.
] |
|
Multi-Ingredient Cold, Flu, and Allergy Medications
|
D26.310.500 |
|
|
Polyethylenes
|
D25.720.716.507 |
|
|
Intracranial Arteriovenous Malformations
|
C14.240.850.750.295 |
|
|
Arteriovenous Malformations
|
C14.240.850.750 |
|
|
Small Ubiquitin-Related Modifier Proteins
|
D12.776.947.249 |
|
|
Receptors, KIR2DL1
|
D054342 |
[A KIR receptor that has specificity for HLA-C ANTIGENS. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL2 RECEPTOR and the KIR2DL3 RECEPTORS.
] |
|
Receptors, KIR2DL2
|
D054343 |
[A KIR receptor that has specificity for HLA-C ANTIGENS. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL1 RECEPTORS and the KIR2DL3 RECEPTORS.
] |
|
Acidobacteria
|
B03.440.400.050 |
|
|
Receptors, KIR
|
D054340 |
[A family of receptors found on NK CELLS that have specificity for a variety of HLA ANTIGENS. KIR receptors contain up to three different extracellular immunoglobulin-like domains referred to as D0, D1, and D2 and play an important role in blocking NK cell activation against cells expressing the appropriate HLA antigens thus preventing cell lysis. Although they are often referred to as being inhibitory receptors, a subset of KIR receptors may also play an activating role in NK cells.
] |
|
Epidemiologic Studies
|
N05.715.360.330.500 |
|
|
Receptors, KIR3DL1
|
D054341 |
[A KIR receptor that has specificity for HLA-B ANTIGENS. It is an inhibitory receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.
] |
|
Receptors, KIR2DL5
|
D054346 |
[An inhibitory KIR receptor that contains D0 and D1 extracellular immunoglobulin-like domains and a long cytoplasmic tail.
] |
|
Receptors, KIR3DL2
|
D054347 |
[A KIR receptor that has specificity for HLA-A3 ANTIGEN. It is an inhibitory receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.
] |
|
Receptors, KIR2DL3
|
D054344 |
[A KIR receptor that has specificity for HLA-C ANTIGEN. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL2 RECEPTORS and the KIR2DL3 RECEPTORS.
] |
|
Receptors, KIR2DL4
|
D054345 |
[A KIR receptor that has specificity for HLA-G antigen. It contains D0 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.
] |
|
Lypressin
|
D12.644.400.900.400 |
|
|
Glycerol-3-Phosphate O-Acyltransferase
|
D08.811.913.050.425 |
|
|
Receptors, KIR3DS1
|
D054349 |
[An activating KIR receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a short cytoplasmic tail.
] |
|
Respiratory Therapy Department, Hospital
|
N02.278.216.500.968.712 |
|
